In doing so, the use of organoid models will be expanded across the US in Parkinson’s disease research. Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary ...

Researchers have used magnetoencephalography brain imaging technology to determine how the drug levodopa, the main drug used ...

Researchers at Simon Fraser University reveal how brain imaging techniques can explain the inconsistent effects of levodopa ...

Simon Fraser University researchers are pioneering personalized Parkinson's treatment using MEG imaging. They discovered that ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Many have heard about Parkinson's Disease. Few know about the disorder and its impact. Even fewer people know how to manage ...

SUNRISE-PD is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled trial with a hybrid decentralized design that will last 20 weeks from the initial screening phase to the safety ...